# Wolf H. Fridman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/wolf-h-fridman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 89,606 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 120 |
| i10-index | 452 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5075098122 |
| ORCID iD | https://orcid.org/0000-0002-1332-0973 |
| Works | 1,040 |

## Researcher papers

- [B cells and tertiary lymphoid structures promote immunotherapy response](https://scholariq.org/papers/b-cells-and-tertiary-lymphoid-structures-promote-immunotherapy-response/)
- [Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures](https://scholariq.org/papers/long-term-survival-for-patients-with-non-small-cell-lung-cancer-with/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.